Abstract
Twelve patients with cutaneous herpes simplex were treated in a double blind series with either 0.1 per cent idoxuridine solution or a placebo. There was no significant difference in healing time between those receiving the drug and those the placebo. The same conclusion was noted in a series of eleven patients using either 1 per cent idoxuridine in a cream or a placebo.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- HALL-SMITH S. P., CORRIGAN M. J., GILKES M. J. Treatment of herpes simplex with 5-iodo-2'-deoxyuridine. Br Med J. 1962 Dec 8;2(5318):1515–1516. doi: 10.1136/bmj.2.5318.1515. [DOI] [PMC free article] [PubMed] [Google Scholar]
- HERTZBERG R. The use of IDU in the treatment of herpes simplex keratitis. Med J Aust. 1963 Jan 5;1(1):13–13. [PubMed] [Google Scholar]
- IVE F. A. A TRIAL OF 5 IODO-2'-DEOXYURIDINE IN HERPES SIMPLEX. Br J Dermatol. 1964 Nov;76:463–464. doi: 10.1111/j.1365-2133.1964.tb15485.x. [DOI] [PubMed] [Google Scholar]
- KAUFMAN H. E., NESBURN A. B., MALONEY E. D. IDU therapy of herpes simplex. Arch Ophthalmol. 1962 May;67:583–591. doi: 10.1001/archopht.1962.00960020583012. [DOI] [PubMed] [Google Scholar]
- SCHOFIELD C. B. THE TREATMENT OF HERPES PROGENITALIS WITH 5 IODO-2'-DEOXYURIDINE. Br J Dermatol. 1964 Nov;76:465–470. doi: 10.1111/j.1365-2133.1964.tb15486.x. [DOI] [PubMed] [Google Scholar]